Paper29427770
Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis.
Cargnin S and 4 others. Pharmacol Res, 2018. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis. Papers, record 29427770. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29427770
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Cytochrome P-450 CYP3A | Major topic |
| Imatinib Mesylate | Major topic |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Major topic |
| Organic Cation Transporter 1 | Major topic |
| Polymorphism, Single Nucleotide | Major topic |
| Asian People | |
| Genotype | |
| Humans |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41455147 | Interindividual variability in imatinib metabolism in human liver microsomes and primary human hepatocytes: Impact of CYP2C8 and CYP3A phenotypes. | Drug Metab Dispos | 2025 | https://conductscience.org/library/papers/41455147 | PubMed |
| 41295218 | The Three Musketeers in Cancer Therapy: Pharmacokinetics, Pharmacodynamics and Personalised Approach. | J Pers Med | 2025 | https://conductscience.org/library/papers/41295218 | PubMed |
| 40868933 | Role of OCT1 and MAP3K5 Genetic Polymorphisms in Hydroxyurea Pharmacokinetics. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40868933 | PubMed |
| 40731166 | Understanding and overcoming multidrug resistance in cancer. | Nat Rev Clin Oncol | 2025 | https://conductscience.org/library/papers/40731166 | PubMed |
| 39523378 | CYP3A4*1B and CYP3A5*3 SNPs significantly impact the response of Egyptian candidates to high-intensity statin therapy to atorvastatin. | Eur J Med Res | 2024 | https://conductscience.org/library/papers/39523378 | PubMed |
| 39143954 | Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy. | Cancer Drug Resist | 2024 | https://conductscience.org/library/papers/39143954 | PubMed |
| 38646295 | Current Progress on the Influence Human Genetics Has on the Efficacy of Tyrosine Kinase Inhibitors Used to Treat Chronic Myeloid Leukemia. | Cureus | 2024 | https://conductscience.org/library/papers/38646295 | PubMed |
| 36882601 | Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia. | Handb Exp Pharmacol | 2023 | https://conductscience.org/library/papers/36882601 | PubMed |
| 36834713 | Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36834713 | PubMed |
| 36467365 | Polymorphisms in drug metabolism genes predict the risk of refractory myasthenia gravis. | Ann Transl Med | 2022 | https://conductscience.org/library/papers/36467365 | PubMed |
| 36294538 | Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients. | J Clin Med | 2022 | https://conductscience.org/library/papers/36294538 | PubMed |
| 36077209 | Genetic Variants of ABC and SLC Transporter Genes and Chronic Myeloid Leukaemia: Impact on Susceptibility and Prognosis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36077209 | PubMed |
| 35720392 | Single Nucleotide Polymorphisms (SNP) and SNP-SNP Interactions of the Surfactant Protein Genes Are Associated With Idiopathic Pulmonary Fibrosis in a Mexican Study Group; Comparison With Hypersensitivity Pneumonitis. | Front Immunol | 2022 | https://conductscience.org/library/papers/35720392 | PubMed |
| 35582588 | Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma. | Cancer Drug Resist | 2019 | https://conductscience.org/library/papers/35582588 | PubMed |
| 35546460 | Evaluation of genetic polymorphism of CYP3A5 in normal healthy participants from western India - A cross-sectional study. | Indian J Pharmacol | 2022 | https://conductscience.org/library/papers/35546460 | PubMed |
| 35456416 | The Role of SLC22A1 and Genomic Ancestry on Toxicity during Treatment in Children with Acute Lymphoblastic Leukemia of the Amazon Region. | Genes (Basel) | 2022 | https://conductscience.org/library/papers/35456416 | PubMed |
| 34262462 | Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34262462 | PubMed |
| 33381028 | Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33381028 | PubMed |
| 31679053 | The genetic landscape of the human solute carrier (SLC) transporter superfamily. | Hum Genet | 2019 | https://conductscience.org/library/papers/31679053 | PubMed |
| 31404235 | Effects of Comedication and Genetic Factors on the Population Pharmacokinetics of Lamotrigine: A Prospective Analysis in Chinese Patients With Epilepsy. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31404235 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP3A5 | 1577 | PubTator's text mining | https://conductscience.org/library/genes/1577 | NCBI Gene |
| SLC22A1 | 6580 | PubTator's text mining | https://conductscience.org/library/genes/6580 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29427770
GET https://conductscience.org/api/papers/v1/29427770/authors